Redefining the Future of Proteomics

Our mission

To advance proteomics with pioneering technology for rapid, high-throughput quantitation of proteoforms, enhancing protein analysis accuracy and efficiency. We empower researchers and biopharma to explore proteome complexities and accelerate scientific breakthroughs.

Our vision

To unlock the full potential of the proteome, advancing biology and medicine. ProQomics, with a platform designed to quantify up to 2,000 proteoforms per minute, aspires to be the global leader in proteomics, empowering researchers to decode protein mysteries and enhance human health.

Our team

Founders

Tamil Selvan Anthonymuthu

Tamil Selvan Anthonymuthu, Ph.D.

Founder & CEO

15+ years of expertise in mass spectrometry and 40 peer-reviewed publications. Before founding ProQomics, Tamil secured $3.8M in SBIR grants for proteomics research, served as Director of R&D at Adeptrix Corp. and was Assistant Professor at the University of Pittsburgh. He brings experience spanning proteomics startups, product development and business growth.

LinkedIn profile of Tamil Selvan Anthonymuthu
Narendra Vaidya

Narendra Vaidya, Ph.D., MBA

Co-Founder & CTO

20+ years in the design, automation, manufacturing and operations of analytical instruments. Naren specializes in systems engineering and high-throughput automation, including IVD device development at PerkinElmer and Johnson & Johnson. At ProQomics he leads instrument architecture and system integration for the ProQFiler™.

LinkedIn profile of Narendra Vaidya